Drug · DIN 02399229
PROQUAD
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 9, 2014; first marketed May 9, 2014.
- Drug Identification Number (DIN)
- 02399229
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Schedule d
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Measles, combinations with mumps, rubella and varicella, live attenuated J07BD54
- Class
- Human
- Record last updated
- November 13, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MEASLES VIRUS LIVE ATTENUATED (EDMONSTON STRAIN) | 3.00 Log10 TCID50 | 0.5 ML |
| MUMPS VIRUS LIVE ATTENUATED (JERYL LYNN STRAIN) | 4.30 Log10 TCID50 | 0.5 ML |
| RUBELLA VIRUS LIVE ATTENUATED (WISTAR RA27/3 STRAIN) | 3.00 Log10 TCID50 | 0.5 ML |
| VARICELLA VIRUS LIVE ATTENUATED (OKA/MERCK STRAIN) | 3.99 Log10 PFU | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 21, 2012: NOC 13960New Drug Submission (NDS)